<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="EN" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Infect Immun</journal-id><journal-id journal-id-type="pmc-domain-id">87</journal-id><journal-id journal-id-type="pmc-domain">iai</journal-id><journal-id journal-id-type="publisher-id">iai</journal-id><journal-title-group><journal-title>Infection and Immunity</journal-title></journal-title-group><issn pub-type="ppub">0019-9567</issn><issn pub-type="epub">1098-5522</issn><publisher><publisher-name>American Society for Microbiology (ASM)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC2632017</article-id><article-id pub-id-type="pmcid-ver">PMC2632017.1</article-id><article-id pub-id-type="pmcaid">2632017</article-id><article-id pub-id-type="pmcaiid">2632017</article-id><article-id pub-id-type="pmid">19047401</article-id><article-id pub-id-type="doi">10.1128/IAI.01017-08</article-id><article-id pub-id-type="publisher-id">1017-08</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Microbial Immunity and Vaccines</subject></subj-group></article-categories><title-group><article-title>The Brucella abortus S19 &#916;<italic>vjbR</italic> Live Vaccine Candidate Is Safer than S19 and Confers Protection against Wild-Type Challenge in BALB/c Mice When Delivered in a Sustained-Release Vehicle<xref ref-type="fn" rid="fn1">&#9663;</xref>  </article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Arenas-Gamboa</surname><given-names initials="AM">A. M.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ficht</surname><given-names initials="TA">T. A.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kahl-McDonagh</surname><given-names initials="MM">M. M.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gomez</surname><given-names initials="G">G.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rice-Ficht</surname><given-names initials="AC">A. C.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff1">2</xref></contrib></contrib-group><aff id="aff1">Department of Veterinary Pathobiology, Texas A&amp;M University, College Station, Texas,<label>1</label> Department of Cellular and Molecular Medicine, College of Medicine, Texas A&amp;M University Health Science Center, College Station, Texas<label>2</label></aff><author-notes><fn id="cor1"><label>*</label><p>Corresponding author. Mailing address: Texas A&amp;M University, Veterinary Pathobiology, College Station, TX 77845-1114. Phone: (979) 845-3466. Fax: (979) 862-7472. E-mail: <email>aarenas@cvm.tamu.edu</email></p></fn></author-notes><pub-date pub-type="ppub"><month>2</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>1</day><month>12</month><year>2008</year></pub-date><volume>77</volume><issue>2</issue><issue-id pub-id-type="pmc-issue-id">175940</issue-id><fpage>877</fpage><lpage>884</lpage><history><date date-type="received"><day>14</day><month>8</month><year>2008</year></date><date date-type="rev-recd"><day>5</day><month>9</month><year>2008</year></date><date date-type="accepted"><day>21</day><month>11</month><year>2008</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>08</month><year>2009</year></date></event><event event-type="pmc-live"><date><day>01</day><month>08</month><year>2009</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2014-04-12 12:07:10.763"><day>12</day><month>04</month><year>2014</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2009, American Society for Microbiology</copyright-statement></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="1017-08.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="pdf" xlink:href="zii00209000877.pdf"/><abstract><p>Brucellosis is an important zoonotic disease of nearly worldwide distribution. Despite the availability of live vaccine strains for bovine (S19, RB51) and small ruminants (Rev-1), these vaccines have several drawbacks, including residual virulence for animals and humans. Safe and efficacious immunization systems are therefore needed to overcome these disadvantages. A <italic>vjbR</italic> knockout was generated in the S19 vaccine and investigated for its potential use as an improved vaccine candidate. Vaccination with a sustained-release vehicle to enhance vaccination efficacy was evaluated utilizing the live S19 &#916;<italic>vjbR</italic>::Kan in encapsulated alginate microspheres containing a nonimmunogenic eggshell precursor protein of the parasite <italic>Fasciola hepatica</italic> (vitelline protein B). BALB/c mice were immunized intraperitoneally with either encapsulated or nonencapsulated S19 &#916;<italic>vjbR</italic>::Kan at a dose of 1 &#215; 10<sup>5</sup> CFU per animal to evaluate immunogenicity, safety, and protective efficacy. Humoral responses postvaccination indicate that the vaccine candidate was able to elicit an anti-<italic>Brucella</italic>-specific immunoglobulin G response even when the vaccine was administered in an encapsulated format. The safety was revealed by the absence of splenomegaly in mice that were inoculated with the mutant. Finally, a single dose with the encapsulated mutant conferred higher levels of protection compared to the nonencapsulated vaccine. These results suggest that S19 &#916;<italic>vjbR</italic>::Kan is safer than S19, induces protection in mice, and should be considered as a vaccine candidate when administered in a sustained-release manner.</p></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group><fn><p><italic>Editor:</italic> A. J. B&#228;umler</p></fn></fn-group></notes></front></article></pmc-articleset>